Home › Funds › Stephens Investment Management Group LLC › TVTX

Stephens Investment Management Group LLC position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

Stephens Investment Management Group LLC reported holding 1,876,683 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$110.5M, representing 1.19% of its reported portfolio and ranking #17 among its reported holdings. Stephens Investment Management Group LLC has disclosed TVTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.88M sh
Reported value held$110.50M
Portfolio Weight1.19%
First reportedQ3 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Stephens Investment Management Group LLC's TVTX position evolved

Stephens Investment Management Group LLC first disclosed a stake in TVTX in Q3 2025 at 1,599,668 shares (US$38.2M). The position peaked in Q3 2026 at 1,876,683 shares, worth US$110.5M. Across 5 filings, Stephens Investment Management Group LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,876,683 shares valued at US$110.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.60M $38.23M New
Q4 2025 1.72M $65.78M Add
Q1 2026 1.80M $53.43M Add
Q2 2026 1.88M $106.54M Add
Q3 2026 1.88M $110.50M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has Stephens Investment Management Group LLC held TVTX?

Stephens Investment Management Group LLC has disclosed TVTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Stephens Investment Management Group LLC's current position in TVTX?

As of Q3 2026, Stephens Investment Management Group LLC holds 1.88M shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $110.50M, representing 1.19% of its reported portfolio and ranking #17.

Has Stephens Investment Management Group LLC been buying or selling TVTX?

In the latest 13F filing (Q3 2026), Stephens Investment Management Group LLC held unchanged its position in TVTX. The position peaked in Q3 2026 at 1.88M shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.